SynthesisBrain and behavior2025
Exploring the Relationship Between Antipsychotic Drug Target Genes and Epilepsy: Evidence From Food and Drug Administration Adverse Event Reporting System Database and Mendelian Randomization.
Synthesis in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of antipsychotic drug target genes and risk of lung cancer: a Mendelian randomization study.Discover oncology · 2025Article
- Causal Inference of Adverse Drug Events in Pulmonary Arterial Hypertension: A Pharmacovigilance Study.Pharmaceuticals (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe effect of antipsychotic drugs on epilepsy is controversial, and we performed Food and Drug Administration Adverse Event Reporting System (FAERS) data mining and Mendelian Randomization (MR) analyses to clarify the effects of target genes on epilepsy.
methodWe explored antipsychotic-induced epilepsy AE signals in FAERS. Gene expression was obtained from the eQTLGen consortium and GTEx project. Epilepsy data were obtained from FinnGen and the International League Against Epilepsy (ILAE). MR, Summary-data-based Mendelian Randomization (SMR), and colocalization analysis were sequentially performed, and meta-analysis was performed on genes with significant expression in MR or SMR to assess the causal relationship between them and epilepsy.
resultThrough FAERS database mining, 63 antipsychotics reported 5121 adverse events in epilepsy. MR identified potential causal associations of 14 drug target genes for epilepsy and its subtypes. MCHR1 and SIGMAR1 were still significant for epilepsy after meta-analysis with no evidence of heterogeneity or pleiotropy. SMR showed that DRD4 and ADRA1D were strongly associated with epilepsy or its subtypes however, neither gene passed the HEIDI test.
conclusionOur study indicates that antipsychotic drugs are associated with a high incidence of epilepsy-related AEs. MR demonstrated a causal relationship between drug targets and epilepsy. Providing new insights for managing epilepsy patients with psychiatric disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.